Hot Products
| Catalog No. | Information |
| CFN97026 | Chrysosplenetin Chrysosplenetin is a metabolic inhibitor of artemisinin, it has strong activity in vitro against EV71 with low cytotoxicity. Co-administration of artemisinin(ART) with chrysosplenetin(CHR) in ratio of 1:2 achieved a synergic anti-malarial effect partly because of the noncompetitive or uncompetitive inhibition of CHR of drug-metabolism enzymes, especially CYP3A which is closely related to the auto-induction of ART. |
| CFN99622 | Chrysosplenol D Chrysosplenol D, an efflux pump inhibitor that can potentiate the activity of commercially important antibiotics and antimalarials. Chrysosplenol D has anti-inflammatory, antimalarial, antibacterial and antifungal activities; it also exerts its anti-proliferative effect on tsFT210 cells through inhibiting cell cycle and inducing apoptosis, it may as a new cell cycle inhibitor. |
| CFN95196 | Cichoriin Cichoriin is a photosensitive compound, it could be used as herbal photosensitizing agent in treating benign breast tumor in rats. |
| CFN90863 | Cimicidanol 3-O-alpha-L-arabinoside Reference standards. |
| CFN70303 | Cimicifugic acid B Cimicifugic acid B shows inhibitory collagenolytic activity. |
| CFN70314 | Cimicifugic acid F Cimicifugic acid F has antioxidant activity. Cimicifugic acid F shows inhibition of neutrophil elastase activity with an IC50 of 18 mumol/L. It also shows strong hyaluronidase inhibitory activity. |
| CFN92973 | Cimicifugoside H1 Cimicifugoside H1 shows the protective function to cerebral neuron during cerebral ischemia. |
| CFN92972 | Cimicifugoside H2 Cimicifugoside H2 is a natural product from Cimicifuga foetida. |
| CFN99465 | Cimidahurinine Cimidahurinine can attenuate Doxorubicin (DOX)-induced cardiotoxicity in a dose-dependent manner with EC50 values of 45.79 uM; it protects against cardiotoxicity by decreasing reactive oxygen species (ROS) accumulation and downregulating apoptosis-related Bax/Bcl-2 proteins. |
| CFN98612 | Cimifugin Cimifugin evidently inhibits FITC-induced type 2 allergic contact dermatitis,and its mechanism might related to regulating the balance of Th1 /Th2 by inhibiting type 2 cytokines. Cimifugin displayed low to moderate inhibition towards AChE and BChE (3.12 and 21.63%, respectively) at 200 ug/mL. |
